Timeline

Voting rights breakdown

Declared beneficial owners · 3

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

• Jacek Szwajcowski15.013%
• Zbigniew Molenda15.013%
• Fritz Oesterle15.013%

Notice details

Beneficial owner

Jacek Szwajcowski

On 26.02.2026, Pelion S.A. and Corporation of European Pharmaceutical Distributors N.V. have entered into an agreement that Pelion S.A. will sell to Corporation of European Pharmaceutical Distributors N.V. all shares in DocMorris AG it holds within 20 business days following the completion of the Annual General Meeting 2026 of DocMorris AG (i.e. by 12 June 2026 the latest, assuming the annual general meeting takes place on 12 May 2026). Such sale was notified by the group arrangement notified hereby by notice published on 05 March 2026. The settlement date of such sale of shares from Pelion S.A. to Corporation of European Pharmaceutical Distributors N.V. is not yet agreed, however, such settlement will only occur after the Annual General Meeting 2026 of DocMorris AG. Until settlement of such sale, Pelion S.A. will remain the shareholder of record of such DocMorris AG shares. As both Pelion S.A. and Corporation of European Pharmaceutical Distributors N.V. are beneficially owned by Jacek Szwajcowski and Zbigniew Molenda, such sale of shares from Pelion S.A. to Corporation of European Pharmaceutical Distributors N.V. does not result in a change of the beneficial ownership of such shares of DocMorris AG but a change of the persons directly involved in the group.